Literature DB >> 7611564

Age-acquired resistance and predisposition to reinfection with Schistosoma haematobium after treatment with praziquantel in Mali.

J F Etard1, M Audibert, A Dabo.   

Abstract

The effect of age, previous intensity of infection, and exposure on reinfection with Schistosoma haematobium after treatment was studied in a cohort of 468 subjects six years of age and over living in an irrigation scheme area in Mali. Prevalence and intensity of S. haematobium infection were measured each year between 1989 and 1991, but the reinfection study period was restricted to the last year of the follow-up. Observations were made at the principal water contact sites where the number of Bulinus truncatus shedding furcocercous cercariae was recorded. A cumulative index of exposure taking into account time, duration and type of contact, and malacologic data was calculated for each subject. Univariate analysis showed that the reinfection risk decreased with age and increased with exposure and pretreatment intensity. These results were confirmed by fitting a logistic model that showed that this risk was seven times lower among those 15 years of age and older than among the 6-14-year-old children, while linear trends with exposure to infection and pretreatment intensity were significant. This study supports the concept of an age-acquired resistance to reinfection and is in favor of a predisposition to infection that raises the question of a genetic factor controlling susceptibility/resistance to S. haematobium infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611564     DOI: 10.4269/ajtmh.1995.52.549

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  Modeling the effect of chronic schistosomiasis on childhood development and the potential for catch-up growth with different drug treatment strategies promoted for control of endemic schistosomiasis.

Authors:  David Gurarie; Xiaoxia Wang; Amaya L Bustinduy; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2011-05       Impact factor: 2.345

2.  Heterogeneities in the transmission of infectious agents: implications for the design of control programs.

Authors:  M E Woolhouse; C Dye; J F Etard; T Smith; J D Charlwood; G P Garnett; P Hagan; J L Hii; P D Ndhlovu; R J Quinnell; C H Watts; S K Chandiwana; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

3.  Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms.

Authors:  Kate M Mitchell; Francisca Mutapi; Nicholas J Savill; Mark E J Woolhouse
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

4.  Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nine-year, school-based treatment program.

Authors:  Sudtida A Satayathum; Eric M Muchiri; John H Ouma; Christopher C Whalen; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2006-07       Impact factor: 2.345

5.  Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children.

Authors:  Kirsten E Lyke; Alassane Dicko; Abdoulaye Dabo; Lansana Sangare; Abdoulaye Kone; Drissa Coulibaly; Ando Guindo; Karim Traore; Modibo Daou; Issa Diarra; Marcelo B Sztein; Christopher V Plowe; Ogobara K Doumbo
Journal:  Am J Trop Med Hyg       Date:  2005-12       Impact factor: 2.345

6.  Prevalence distribution and risk factors for Schistosoma hematobium infection among school children in Blantyre, Malawi.

Authors:  Atupele P Kapito-Tembo; Victor Mwapasa; Steven R Meshnick; Young Samanyika; Dan Banda; Cameron Bowie; Sarah Radke
Journal:  PLoS Negl Trop Dis       Date:  2009-01-20

7.  Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E.

Authors:  Colin M Fitzsimmons; Sarah Joseph; Frances M Jones; Claus M Reimert; Karl F Hoffmann; Francis Kazibwe; Gachuhi Kimani; Joseph K Mwatha; John H Ouma; Edridah M Tukahebwa; Henry C Kariuki; Birgitte J Vennervald; Narcis B Kabatereine; David W Dunne
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

8.  Partnering parasites: evidence of synergism between heavy Schistosoma haematobium and Plasmodium species infections in Kenyan children.

Authors:  Lia S Florey; Charles H King; Melissa K Van Dyke; Eric M Muchiri; Peter L Mungai; Peter A Zimmerman; Mark L Wilson
Journal:  PLoS Negl Trop Dis       Date:  2012-07-24

9.  Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach.

Authors:  Stefanie Knopp; Khalfan A Mohammed; Said M Ali; I Simba Khamis; Shaali M Ame; Marco Albonico; Anouk Gouvras; Alan Fenwick; Lorenzo Savioli; Daniel G Colley; Jürg Utzinger; Bobbie Person; David Rollinson
Journal:  BMC Public Health       Date:  2012-10-30       Impact factor: 3.295

10.  Repeated Schistosoma japonicum infection following treatment in two cohorts: evidence for host susceptibility to helminthiasis?

Authors:  Elizabeth J Carlton; Alan Hubbard; Shuo Wang; Robert C Spear
Journal:  PLoS Negl Trop Dis       Date:  2013-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.